The current position： Home>Technology

Technology
- 干細胞
- 免疫細胞

Translational medicine
- 干細胞治療
- 免疫細胞治療

Academic center

Jilin Zhongke Bio-engineering Co., Ltd. (JZB) founded in May 2007. JZB registered address is Changchun City, Jilin Province of P. R. China. Registered capital is 100 million RMB. JZB mainly engaged ... [more]

Technology

Authoritativeness

We have built the CHINA CONTINUING MEDICAL STEM CELLS TRANSPLATION TECHNOLOGY CLINICAL APPLICATION. We have made important breakthrough in the stem cell application to the treatment of many kinds of disease.

上一篇：A New Milestone: US released the Phase II Stem Cell Clinical Trials

下一篇：Safety

Hepatology Hospital
China-Japan Union Hospital
The Second Hospital
Hospital Jilin Province
The Third Hospital
The First Hospital

欧美日韩精品,成人欧美一区二区三区视频不卡 ,高H粗口调教羞辱SM文女王动画,久久国产精品夜色

Authoritativeness